Skip to content



Session Title: Risk, Grit and Resiliency
Speaker: Charles J. Lockwood, Senior Vice President, USF Health Dean, USF Health Morsani College of Medicine      
Watch the session:

Bio: Dr. Charles J. Lockwood is Senior Vice President for USF Health, Dean of the Morsani College of Medicine and Professor of Obstetrics & Gynecology and Public Health at the University of South Florida.  He also serves as an Executive Vice President at Tampa General Hospital. Previously he was Dean at The Ohio State University College of Medicine and chaired Ob/Gyn departments at Yale and New York University. He graduated magna cum laude from Brown University, received his M.D. from the University of Pennsylvania and a Master’s in Healthcare Management from the Harvard School of Public Health. Lockwood served his Ob/Gyn residency at Pennsylvania Hospital, a Maternal-Fetal Medicine fellowship at Yale and a post-doctoral research fellowship at Mt. Sinai School of Medicine.  His research has been funded by over two decades of federal and foundation support.  He has published over 300 peer-reviewed publications (Google H-index of 79; 22,313 citations), 280 editorials, chapters and invited reviews, co-authored 5 monographs and co-edited 6 textbooks, 3 with multiple editions. He is credited with leading the research team that discovered fetal fibronectin as a predictor of impending preterm birth and discovering the role of stromal cell tissue factor expression in regulating endometrial hemostasis and menstruation. Lockwood has also been on multiple journal editorial boards and is the long-standing Editor-in-Chief of Contemporary OB/GYN where his editorials have won six national publication awards. He has chaired and/or served on numerous NIH and FDA review panels, been an examiner for the American Board of Obstetrics and Gynecology, chaired multiple American College of Obstetricians and Gynecologists (ACOG) committees, and serves as a medical school accreditation reviewer for LCME. He has also served as president of the Society for Reproductive Investigation (SRI) and the American Gynecological and Obstetrical Society and currently serves on the National Board of the March of Dimes and the Foundation Board of the Society for Maternal-Fetal Medicine (SMFM). He is a member of the Sigma Xi and Alpha Omega Alpha research and medical honour societies, respectively, been named to national and regional “Best Doctors” lists annually since 1995, and has received multiple research awards including the SRI’s Distinguished Scientist Award, the NICHD Frontiers in Reproduction Beacon Award and the SMFM Lifetime Achievement Award. He is a recipient of the U.S. FDA Advisory Committee Service Award and ACOG’s Public Service Award for his “enduring commitment to women’s health.” He has been elected to the American Association for the Advancement of Science (AAAS) and the U.S. National Academy of Medicine.